France Biotech publishes 3rd edition of its review of product development pipelines in French life science companies
In 2008, the number of drugs and medical devices in late-stage development rose markedly, thanks to significant levels of investment over the period 2005-2007
04-Mar-2009 -
France Biotech has published the 3rd edition of its annual Drug Pipeline Review. The survey was part-funded by the French Ministry of the Economy, Industry & Finance.
The study summarizes and analyses data collected in 2008 on 227 healthcare products under development, including 158 drugs (at 51 ...
diagnostics
drug development
Life Sciences
+1